

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | MEK ↓ ↑ | MEK1 ↓ ↑ | MEK1/2 ↓ ↑ | MEK2 ↓ ↑ | MEK5 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Honokiol | ✔ | 98% | |||||||||||||||||
| Mirdametinib |
++++
MEK, IC50: 0.33 nM |
99%+ | |||||||||||||||||
| Binimetinib |
+++
MEK, IC50: 12 nM |
99%+ | |||||||||||||||||
| BI-847325 |
++
MEK1, IC50: 25 nM |
+++
MEK2, IC50: 4 nM |
99%+ | ||||||||||||||||
| U0126-EtOH |
+
MEK1, IC50: 0.07 μM |
++
MEK2, IC50: 0.06 μM |
98% | ||||||||||||||||
| GDC-0623 |
++++
MEK1, IC50: 0.13 nM |
99%+ | |||||||||||||||||
| TAK-733 |
++++
MEK1, IC50: 3.2 nM |
99%+ | |||||||||||||||||
| Trametinib |
++++
MEK1, IC50: 0.92 nM |
++++
MEK2, IC50: 1.8 nM |
99%+ | ||||||||||||||||
| Selumetinib |
+++
MEK1, IC50: 14 nM MEK1, Kd: 99 nM |
+
MEK2, Kd: 530 nM |
99%+ | ||||||||||||||||
| CI-1040 |
++
MEK1, IC50: 17 nM |
++
MEK2, IC50: 17 nM |
99%+ | ||||||||||||||||
| Myricetin | ✔ | 98% | |||||||||||||||||
| Refametinib |
++
MEK1, IC50: 19 nM |
++
MEK2, IC50: 47 nM |
99%+ | ||||||||||||||||
| Cobimetinib |
+++
MEK1, IC50: 4.2 nM |
99%+ | |||||||||||||||||
| PD98059 |
+
MEK1, IC50: 2 μM |
99%+ | |||||||||||||||||
| SL327 |
+
MEK1, IC50: 0.18 μM |
+
MEK2, IC50: 0.22 μM |
AP-1 | 98+% | |||||||||||||||
| PD318088 | ✔ | 99% | |||||||||||||||||
| AZD8330 |
+++
MEK1/2, IC50: 7 nM |
99%+ | |||||||||||||||||
| Pimasertib | 98% | ||||||||||||||||||
| (E/Z)-BIX02189 |
++++
MEK5, IC50: 1.5 nM |
99%+ | |||||||||||||||||
| (E/Z)-BIX02188 |
+++
MEK5, IC50: 4.3 nM |
99% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 产品名称 | TNF-α ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thalidomide | ✔ | E3 Ligase | 98% | ||||||||||||||||
| GSK2982772 |
++
human RIP1, IC50: 16 nM |
99%+ | |||||||||||||||||
| QNZ |
++++
TNF-α, IC50: 7 nM |
NF-κB | 99%+ | ||||||||||||||||
| Lenalidomide |
+++
TNF-α, IC50: 13 nM |
99% | |||||||||||||||||
| Pomalidomide |
+++
TNF-α, IC50: 13 nM |
98% | |||||||||||||||||
| GSK481 | ✔ | 99%+ | |||||||||||||||||
| Apremilast |
++
TNF-α, IC50: 77 nM |
98% | |||||||||||||||||
| Necrostatin-1 |
+
RIP1, EC50: 490 nM |
99%+ | |||||||||||||||||
| Acetylcysteine | ✔ | 98% | |||||||||||||||||
| Adalimumab | ✔ | 98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) belongs to serine-threonine kinase family and is activated directly by stress and inflammatory signal through p38MAPK phosphorylation in diverse inflammatory conditions through the Toll-like receptor signaling pathway. MK2 has been thought to be a critical factor involved in the regulation of synthesis and release of pro-inflammatory (TNF-α, IL-6 and IL-1β, etc.) proteins[3]. PF-3644022 is a potent, selective, orally active and ATP-competitive MK2 inhibitor. In the human U937 monocytic cell line or peripheral blood mononuclear cells, PF-3644022 potently inhibits TNFalpha production with similar activity (IC50 = 160 nM). PF-3644022 blocks TNFalpha and IL-6 production in LPS-stimulated human whole blood with IC50 of 1.6 and 10.3 mM, respectively.[4]. PF-3644022 increases the expression of Arg1 and decreases iNOS. Realtime PCR revealed the increased expressions of inflammation related factors (such as IL-1β, NF-κB, TNF-α, MK2) and pro-apoptotic gene (Bax). The BMS score showed a reduced motor function of the twy/twy mice. The motor function was also enhanced with the treatment of PF-3644022[5]. |
| Concentration | Treated Time | Description | References | |
| SCC47 (HPV+) | 50 µM | 48 hours | RT increased MK2 protein phosphorylation while MK2 inhibitor alone did the opposite. Dual RT+MK2i treatment prevented RT-induced MK2 phosphorylation. | Oncogene. 2019 Nov;38(48):7329-7341 |
| TU167 (HPV−) | 50 µM | 48 hours | RT increased MK2 protein phosphorylation while MK2 inhibitor alone did the opposite. Dual RT+MK2i treatment prevented RT-induced MK2 phosphorylation. | Oncogene. 2019 Nov;38(48):7329-7341 |
| Administration | Dosage | Frequency | Description | References | ||
| MMTV-Her2 mice | MMTV-Her2 breast cancer model | Oral | 5 μM | 14 days | PF3644022 reduced Hsp27-Ser86 phosphorylation and percentage of E-cadherinhigh ducts and increased β-catenin nuclear translocation in mammary glands. PF3644022 did not alter the percentage of ducts with early lesions in mammary glands, but increased the Her2+ eDCCs in blood, bone marrow and lung. | Oncogene. 2020 Oct;39(40):6313-6326. |
| Mice | HN009LN (p16−) and HN011T (p16+) PDX models | Peritumoral injection | 50µM | Every other day for a total of 6 injections | Dual RT+MK2i treatment significantly decreased tumor volumes and improved animal survival. | Oncogene. 2019 Nov;38(48):7329-7341 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.67mL 0.53mL 0.27mL |
13.35mL 2.67mL 1.34mL |
26.71mL 5.34mL 2.67mL |
|
| CAS号 | 1276121-88-0 |
| 分子式 | C21H18N4OS |
| 分子量 | 374.46 |
| SMILES Code | O=C1N[C@H](C)CNC2=C1SC3=CC=C4N=C(C5=CC=C(C)N=C5)C=CC4=C32 |
| MDL No. | MFCD21363374 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | CMWRPDHVGMHLSZ-GFCCVEGCSA-N |
| Pubchem ID | 44631903 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 40 mg/mL(106.82 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1